Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Shanghai Ark Biopharmaceutical Co., Ltd.

Clinical trials sponsored by Shanghai Ark Biopharmaceutical Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug AK0406 takes first step: will it be safe? Results expected Apr 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet recruiting 2 Completed 3 Terminated 1

New antiviral pill aims to shorten RSV symptoms in vulnerable adults

Disease control Recruiting now

This study tests an oral antiviral called ziresovir (AK0529) in adults at high risk for severe RSV infection, such as those with chronic lung or heart disease, weakened immune systems, or age 65 and older. Participants receive either the drug or a placebo, and researchers measure…

Phase 2/3 • Sponsor: Shanghai Ark Biopharmaceutical Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 14:01 UTC